The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand?
Enormous progress has been made globally in the use of evidence derived from patients'
clinical information as they access their routine medical care. The value of real-world data …
clinical information as they access their routine medical care. The value of real-world data …
Nitrogen mustards as alkylating agents: a review on chemistry, mechanism of action and current USFDA status of drugs
GS More, AB Thomas, SS Chitlange… - Anti-Cancer Agents …, 2019 - ingentaconnect.com
Background & Objective: Nitrogen mustard derivatives form one of the major classes of anti-
cancer agents in USFDA approved drugs list. These are polyfunctional alkylating agents …
cancer agents in USFDA approved drugs list. These are polyfunctional alkylating agents …
Effects of an e-Prescribing interface redesign on rates of generic drug prescribing: exploiting default options
S Malhotra, AD Cheriff, JT Gossey… - Journal of the …, 2016 - academic.oup.com
Objective Increasing the use of generic medications could help control medical costs.
However, educational interventions have limited impact on prescriber behavior, and e …
However, educational interventions have limited impact on prescriber behavior, and e …
Societal value of generic medicines beyond cost-saving through reduced prices
P Dylst, A Vulto, S Simoens - Expert review of pharmacoeconomics …, 2015 - Taylor & Francis
Objective: This paper aims to provide an overview of the added societal value of generic
medicines beyond their cost-saving potential through reduced prices. In addition, an …
medicines beyond their cost-saving potential through reduced prices. In addition, an …
[HTML][HTML] Impact of substitution among generic drugs on persistence and adherence: a retrospective claims data study from 2 local healthcare units in the Lombardy …
GL Colombo, E Agabiti-Rosei, A Margonato… - Atherosclerosis …, 2016 - Elsevier
Background The use of generics, equivalent but less expensive drugs, is an important
opportunity to reduce healthcare expenditure. Methods The purpose of this study was to …
opportunity to reduce healthcare expenditure. Methods The purpose of this study was to …
Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis
J Leclerc, M Thibault, J Midiani Gonella, C Beaudoin… - Drugs, 2020 - Springer
Abstract Background Previous systematic reviews (2008; 2016) concluded similarity in
outcomes between brand-name and generic drugs in cardiology, but they included≥ 50 …
outcomes between brand-name and generic drugs in cardiology, but they included≥ 50 …
Prescribing behavior of general practitioners for generic drugs
The factors influencing General Practitioners'(GPs) prescribing behavior are diverse in terms
of health care policies and regulations, GPs' education and experience, demographic trends …
of health care policies and regulations, GPs' education and experience, demographic trends …
Improving adherence to treatment and reducing economic costs of hypertension: the role of olmesartan-based treatment
FV Costa - High Blood Pressure & Cardiovascular Prevention, 2017 - Springer
Poor adherence to antihypertensive treatment is the single most important factor of
unsatisfactory blood pressure (BP) control. This review focuses on therapy-related factors …
unsatisfactory blood pressure (BP) control. This review focuses on therapy-related factors …
Generic antiretroviral drugs and HIV care: an economic review
Y Yazdanpanah, M Schwarzinger - Médecine et Maladies Infectieuses, 2016 - Elsevier
The cost of HIV care in European countries is high. Direct medical costs, in France, have
been estimated at 500,000 Euros per patient's lifetime (20,000 Euros/year/patient). Overall …
been estimated at 500,000 Euros per patient's lifetime (20,000 Euros/year/patient). Overall …
Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the US Food and Drug Administration …
Abstract Background The US Food and Drug Administration Adverse Event Reporting
System (FAERS), a post-marketing safety database, can be used to differentiate brand …
System (FAERS), a post-marketing safety database, can be used to differentiate brand …